LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

LLY

988.57

+2.13%↑

JNJ

225.57

+0.63%↑

ABBV

206.03

-1.03%↓

NVS

145.46

+0.64%↑

MRK

113.2

+0.05%↑

Home・Aktien・Avidity Biosciences Inc

Avidity Biosciences Inc

Geschlossen

BrancheGesundheitswesen

15.05

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.05

Max

15.05

Schlüsselkennzahlen
By Trading Economics
Einkommen	-63M -237M
Verkäufe	-12M 860K
EPS	-1.27
Gewinnspanne	-27,569.884
Angestellte	511
EBITDA	-59M -232M

Empfehlungen
By TipRanks
Empfehlungen	Neutral
12-Monats-Prognose	-0.1% downside

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-9B 2.3B
Vorheriger Eröffnungskurs	15.05
Vorheriger Schlusskurs	15.05

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

25.575 / 32.65 Unterstützung & Widerstand

Avidity Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. März 2026, 23:01 UTC

Ergebnisse

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises - Update

5. März 2026, 21:54 UTC

Ergebnisse

Costco Posts Higher 2Q Profit on Rising Sales, Membership Fees

5. März 2026, 21:35 UTC

Wichtige Markttreiber

ServiceNow Shares Rise After CEO Says AI Can Add Value to Software

6. März 2026, 00:00 UTC

Wichtige Nachrichtenereignisse

Its Missile Threat Degraded, Iran Is Taking Fewer Shots at More Targets -- WSJ

5. März 2026, 23:46 UTC

Market Talk

Nikkei May Decline Amid Concerns About Energy Costs -- Market Talk

5. März 2026, 23:33 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

5. März 2026, 23:27 UTC

Market Talk

Middle East Fighting Will Prompt RBA to Delay Hike -- Market Talk

5. März 2026, 22:54 UTC

Market Talk

Ergebnisse

Costco Sold a $150,000 Diamond Ring in 2Q -- Market Talk

5. März 2026, 22:50 UTC

Market Talk

Woodside Has More Exposure to Rising Gas Prices Than Santos -- Market Talk

5. März 2026, 22:48 UTC

Ergebnisse

Nike Reports $300 Million Pretax Charge Related to Job Cuts -- Barrons.com

5. März 2026, 22:46 UTC

Ergebnisse

Costco Evaluating Possibility of Tariff Refunds as 2Q Revenue Rises -- Update

5. März 2026, 22:44 UTC

Ergebnisse

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5. März 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

5. März 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

5. März 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

5. März 2026, 21:35 UTC

Ergebnisse

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5. März 2026, 21:32 UTC

Ergebnisse

Costco Earnings Beat Expectations as Membership Model Shines -- Barrons.com

5. März 2026, 21:26 UTC

Ergebnisse

These Stocks Are Today's Movers: Broadcom, Trade Desk, Berkshire Hathaway, Rigetti, Corning, Ciena, Expedia, and More -- Barrons.com

5. März 2026, 21:24 UTC

Ergebnisse

Costco February Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 20.8% >COST

5. März 2026, 21:23 UTC

Ergebnisse

Costco February Same-Store Sales Ex-Changes in Gas and Foreign Exchange Rose 7% >COST

5. März 2026, 21:22 UTC

Ergebnisse

Costco 2Q Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5. März 2026, 21:21 UTC

Ergebnisse

Costco February Digitally-Enabled Sales Rose 21.8% >COST

5. März 2026, 21:21 UTC

Ergebnisse

Costco Total Co Comparable Sales for February Rose 7.9% >COST

5. März 2026, 21:20 UTC

Ergebnisse

Costco February Net Sales Were $21.69 B >COST

5. März 2026, 21:20 UTC

Ergebnisse

Marvell Earnings Beat Estimates on 'Robust' AI Demand. The Stock Jumps. -- Barrons.com

5. März 2026, 21:20 UTC

Ergebnisse

Costco Same-Store Sales Ex-Changes in Gas and Foreign Rose 6.7% >COST

5. März 2026, 21:19 UTC

Ergebnisse

Costco 2Q Digitally-Enabled Sales Ex-Changes in Gas and Foreign Exchange Rose 21.7% >COST

5. März 2026, 21:18 UTC

Ergebnisse

Costco 2Q Digitally-Enabled Sales Rose 22.6% >COST

5. März 2026, 21:18 UTC

Ergebnisse

Costco 2Q Same-Store Sales Up 7.4% >COST

5. März 2026, 21:15 UTC

Ergebnisse

Costco 2Q EPS $4.58 >COST

Peer-Vergleich

Kursveränderung

Avidity Biosciences Inc Prognose

Kursziel

By TipRanks

-0.1% Nachteil

12-Monats-Prognose

Durchschnitt 72.75 USD -0.1%

Hoch 75 USD

Tief 72 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Avidity Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Avidity Biosciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

25.575 / 32.65Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

Recent bearish events outweigh bullish events.

Finanzen

Über Avidity Biosciences Inc

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.